Vitamin D Explained: Understanding Your Vitamin D Blood Test Results

This article provides general health education. It cannot diagnose vitamin D deficiency, osteomalacia, osteoporosis or another medical condition and does not recommend an individual dose of vitamin D.

Vitamin D results should be interpreted using the reporting laboratory's reference interval alongside age, symptoms, medical history, medications, kidney and liver function, calcium and phosphate status, diet, supplement use and the clinical reason for testing.

High-dose vitamin D used to treat established deficiency is different from routine nutritional supplementation and should be managed according to appropriate clinical guidance.

Vitamin D has become one of the most discussed nutrients in modern healthcare.

It appears on supplement bottles, wellness panels and private blood-test packages. Low vitamin D has been associated in observational studies with an enormous range of conditions, from cardiovascular disease and cancer to diabetes, infections and depression.

This has created a seductive but scientifically dangerous assumption:

If low vitamin D is associated with poor health, raising vitamin D must prevent those diseases.

That conclusion does not automatically follow.

People who are unwell may spend less time outdoors. People with chronic disease may exercise less, have different diets or have conditions affecting vitamin D metabolism. Obesity influences circulating 25(OH)D concentrations. Age, skin pigmentation, geography, season and behaviour also affect vitamin D status.

Consequently, low vitamin D can sometimes be a marker associated with other characteristics rather than the direct cause of every condition with which it correlates.

Randomised clinical trials are therefore crucial.

The 2024 Endocrine Society guideline represents an important change in how vitamin D is discussed. After evaluating contemporary trial evidence, its panel concluded that healthy adults generally do not need routine vitamin D blood testing and that disease-specific target concentrations have not been established for healthy populations.

That does not make vitamin D unimportant.

True deficiency is real. Severe deficiency damages bone mineralisation. Rickets and osteomalacia remain clinically important diseases. People with malabsorption, limited sunlight exposure and certain medical conditions can be particularly vulnerable.

The evidence instead requires a more nuanced message:

Vitamin D is essential. Deficiency matters. But more vitamin D is not automatically better, and testing every healthy person does not necessarily improve health.

That distinction is central to interpreting your result properly.

Despite its name, vitamin D behaves partly like a hormone.

The two principal forms relevant to humans are:

Vitamin D3 — cholecalciferol Produced in the skin following ultraviolet-B exposure and found in some animal-derived foods and supplements.

Vitamin D2 — ergocalciferol Derived primarily from fungal or plant-related sources and used in some fortified foods and supplements.

Both forms ultimately enter the body's vitamin D metabolic pathway.

Vitamin D itself is not the final active molecule. It undergoes sequential processing, principally in the liver and kidneys.

Understanding this pathway explains why several different "vitamin D" molecules can appear on laboratory reports.

The process can be simplified into three stages.

Step 1 — Skin

Ultraviolet-B radiation reaching exposed skin converts a cholesterol-related precursor into vitamin D3.

This makes sunlight an important natural source.

But production varies enormously according to:

latitude, season, time of day, skin pigmentation, clothing, time spent outdoors, age, weather and atmospheric conditions.

In the UK, ultraviolet-B radiation is insufficient for meaningful skin vitamin D synthesis during much of autumn and winter. NHS advice therefore recommends considering supplementation during these months.

Step 2 — Liver

Vitamin D is converted principally in the liver to:

25-hydroxyvitamin D — 25(OH)D

also known as:

calcidiol or calcifediol.

This is the molecule usually measured when clinicians want to assess vitamin D status.

Step 3 — Kidney and other tissues

25(OH)D undergoes further hydroxylation, predominantly in the kidneys, producing:

1,25-dihydroxyvitamin D — 1,25(OH)₂D

also called:

calcitriol.

This is the biologically active hormonal form.

Calcitriol influences calcium and phosphate homeostasis, including intestinal calcium absorption.

The names look similar but the tests answer different questions.

25(OH)D is preferred because it reflects vitamin D obtained from both endogenous production and dietary/supplement sources and remains in circulation substantially longer.

Measuring calcitriol instead can actually be misleading in straightforward nutritional deficiency because hormonal regulation may maintain or even increase calcitriol despite depleted vitamin D stores.

1,25(OH)₂D testing has specialist uses—for example, in selected disorders involving calcium, phosphate, kidney function or abnormal vitamin D metabolism—but it is not simply a "more accurate vitamin D test."

For routine vitamin D status, the apparently less "active" 25(OH)D measurement is considerably more useful.

Vitamin D is commonly reported in:

nmol/L — nanomoles per litre

or

ng/mL — nanograms per millilitre.

The conversion is:

1 ng/mL = 2.5 nmol/L

and:

1 nmol/L = 0.4 ng/mL.

So:

This becomes important when comparing US and UK information online.

A US website describing "20 ng/mL" is discussing 50 nmol/L, not 20 nmol/L.

There is no single globally accepted answer.

This is one of the most important facts in this guide.

UK SACN framework

SACN concluded that the risk of poor musculoskeletal health increases when 25(OH)D falls below:

25 nmol/L

Its dietary recommendations were designed to help most of the UK population remain at or above this concentration even when UVB exposure is minimal.

US National Academies framework

The US Food and Nutrition Board uses a somewhat different framework:

These should not be treated as competing laboratory diagnoses. They were developed within different nutritional frameworks.

Why You May See "75 nmol/L" Online

For years, some professional groups, clinicians and commercial wellness services promoted substantially higher vitamin D targets—often 75 nmol/L (30 ng/mL) or more.

The evidence supporting universal higher targets has become increasingly controversial.

The Endocrine Society's 2024 guideline explicitly states that it no longer endorses specific 25(OH)D thresholds for sufficiency, insufficiency and deficiency in generally healthy people, because outcome-specific thresholds have not been established in clinical trials.

That is a significant change.

This is why Healio360 avoids presenting a single internet-derived "optimal" vitamin D number as universal medical truth.

Testing can be useful when there is a clinical reason.

Examples can include suspected:

osteomalacia, rickets, abnormalities in calcium or phosphate, significant malabsorption, selected metabolic bone disease, symptoms compatible with clinically important deficiency, or other conditions in which vitamin D status materially affects management.

Historical NICE public-health guidance advised against routine testing unless someone had symptoms, particularly high risk or another clinical reason such as osteomalacia or a fall.

The Endocrine Society's 2024 evidence review similarly recommends against routine screening in otherwise healthy adults.

This can initially seem counterintuitive.

If vitamin D is important, why not measure everyone?

Because screening is useful only when knowing the result reliably changes management in a way that improves health outcomes.

There are several problems with universal testing:

1. Optimal targets remain uncertain.

2. Assays vary. Different laboratory methods can produce somewhat different measurements.

3. Vitamin D varies seasonally.

4. Mildly low concentrations are common.

5. Testing can encourage unnecessary high-dose supplementation.

6. Trials have not demonstrated that targeting arbitrary higher concentrations improves broad health outcomes in otherwise healthy adults.

This is why modern guidance increasingly separates preventing nutritional deficiency from testing and treating everyone toward a numerical target.

Low 25(OH)D usually results from one or more factors affecting production, intake, absorption or metabolism.

Limited sunlight exposure

This is one of the most important factors in the UK.

People who spend little time outdoors, are housebound, live in institutions or cover most of their skin outdoors may have less opportunity for cutaneous vitamin D production.

Darker skin pigmentation

Melanin absorbs ultraviolet radiation, meaning more UVB exposure is generally required to generate the same amount of vitamin D compared with lighter skin.

UK public-health guidance therefore recognises people with dark skin, including many people of African, African-Caribbean and South Asian backgrounds, as being at greater risk of low vitamin D status.

Importantly, this does not mean every person with dark skin needs routine blood testing. The Endocrine Society specifically recommends against routine screening based solely on dark complexion in otherwise healthy adults.

Season and latitude

At northern latitudes, winter sunlight contains insufficient UVB for meaningful vitamin D synthesis.

This explains the UK's seasonal supplement advice.

Low dietary intake

Vitamin D occurs naturally in relatively few foods.

Sources include oily fish and some animal products, while fortified foods can contribute significantly depending on the country and product.

SACN notes that obtaining the full UK RNI from natural foods alone can be difficult.

Malabsorption

Conditions affecting intestinal absorption can reduce uptake of fat-soluble vitamins including vitamin D.

Examples may include certain forms of:

coeliac disease, inflammatory bowel disease, pancreatic disease, cholestatic liver disease, and gastrointestinal surgery.

These situations require individual clinical interpretation rather than routine population advice.

Obesity

People with obesity often have lower measured circulating 25(OH)D concentrations.

The mechanisms are complex and may include distribution into a larger body compartment and metabolic differences.

However, the Endocrine Society concluded that routine vitamin D screening in otherwise healthy adults with obesity has not been shown to improve outcomes and therefore recommends against it.

Kidney and liver disorders

The liver and kidneys are central to vitamin D metabolism, so significant disease affecting these organs can alter vitamin D handling.

Interpretation in these settings can differ substantially from routine nutritional vitamin D assessment.

Mild biochemical deficiency may cause no obvious symptoms.

When deficiency becomes clinically significant, particularly when it impairs bone mineralisation, manifestations can include:

bone pain, muscle weakness, difficulty with mobility, and increased skeletal fragility.

Severe deficiency causes osteomalacia in adults and rickets in children.

But this needs an important qualification.

Symptoms such as fatigue, muscle aches and generalised pain are extremely nonspecific.

They can occur in many medical conditions and in people without identifiable disease.

Therefore:

A low vitamin D result does not automatically prove that vitamin D caused every symptom a person is experiencing.

Likewise, finding low vitamin D should not necessarily end the investigation of significant persistent symptoms.

Vitamin D's strongest established role concerns the musculoskeletal system.

Vitamin D promotes calcium absorption and participates in calcium and phosphate regulation. Without adequate vitamin D, normal mineralisation of newly formed bone becomes impaired.

Severe prolonged deficiency can therefore cause osteomalacia.

But an important distinction exists between:

correcting true deficiency

and

giving extra vitamin D to already vitamin-D-replete healthy adults to prevent fractures.

These are not the same clinical question.

A major VITAL ancillary trial published in the New England Journal of Medicine followed 25,871 generally healthy midlife and older adults who were not selected for vitamin D deficiency, osteoporosis or low bone mass.

Vitamin D3 at 2,000 IU/day did not significantly reduce total fractures, nonvertebral fractures or hip fractures compared with placebo over a median 5.3 years.

This does not show that vitamin D is irrelevant to bone.

It shows that:

Correcting deficiency and giving extra vitamin D indiscriminately to generally healthy people are fundamentally different interventions.

Severe vitamin D deficiency can be associated with muscle weakness.

However, trials of supplementation in people without substantial deficiency have produced inconsistent results.

The NIH evidence review describes studies in older adults where raising 25(OH)D substantially did not produce significant improvements in muscle strength or physical performance.

Again, supplementation should not be conceptualised as a universal performance enhancer.

Vitamin D receptors are present in many immune cells, and vitamin D participates in immune regulation.

This biological plausibility has generated enormous interest in whether supplementation prevents respiratory infections, autoimmune disease and other immune-related conditions.

But biological plausibility is not the same as proven clinical benefit.

Clinical trial evidence varies according to population, baseline status, dosing and outcome.

The Endocrine Society's 2024 guideline concluded that certain populations—including children and adolescents—may derive some preventive benefits from empiric supplementation, but it did not establish a universal blood concentration that people should target for immune optimisation.

Observational studies have repeatedly found relationships between vitamin D concentrations and cancer outcomes.

But supplementation trials tell a more complicated story.

The NIH evidence review reports that meta-analyses of randomised trials generally do not show reduced overall cancer incidence from vitamin D supplementation, although some analyses have suggested modest reductions in cancer mortality.

This distinction matters.

An association between low vitamin D and cancer does not mean vitamin D deficiency necessarily caused the cancer.

Nor does it justify high-dose vitamin D as a cancer-prevention strategy.

Observational studies have associated lower vitamin D levels with cardiovascular disease.

However, randomised trials have provided little support for vitamin D supplementation preventing cardiovascular events in the general population.

This is another example of why correlation and causation must be separated.

Observational study: people with lower vitamin D have more disease.

Possible interpretation: low vitamin D causes disease.

Alternative interpretation: illness, obesity, inactivity, diet, socioeconomic factors or reduced outdoor exposure cause both lower vitamin D and poorer health.

Randomised trial: supplement vitamin D and see whether disease decreases.

When trial results fail to reproduce strong observational associations, the causal story becomes much less certain.

The 2024 Endocrine Society guideline identified adults with high-risk prediabetes as one group in whom vitamin D supplementation beyond standard dietary intake may modestly reduce progression to diabetes, based on its evidence synthesis.

That does not mean vitamin D is a treatment for diabetes or that everyone with an elevated HbA1c should self-prescribe high doses.

Lifestyle, body weight, metabolic risk and established diabetes-prevention strategies remain central.

Vitamin D represents one component of a much larger clinical picture.

Vitamin D requirements during pregnancy have received considerable research attention.

UK SACN recommendations include pregnant and breastfeeding women within the 10 microgram/day (400 IU) RNI.

The Endocrine Society's 2024 guideline suggests empiric vitamin D supplementation during pregnancy based on evidence suggesting potential reductions in outcomes including pre-eclampsia, preterm birth and some adverse neonatal outcomes.

However, the trials used widely varying doses, and the guideline does not recommend routine 25(OH)D testing in healthy pregnancy.

Older adults deserve particular attention for several reasons.

Skin vitamin D production becomes less efficient with age, while frailty and reduced outdoor activity can further reduce sunlight exposure.

The Endocrine Society suggests empiric vitamin D supplementation in adults 75 years and older, based on evidence suggesting a potential mortality benefit, but again recommends against routine blood-level screening in otherwise healthy older adults.

This demonstrates an important principle:

You do not always need a blood test before following population-level nutritional guidance.

Food sources include:

oily fish such as salmon, sardines, herring and mackerel, egg yolks, liver, some meats, and fortified foods.

Fortified foods can include certain breakfast cereals, spreads and plant-based products, although amounts vary.

SACN's 2023 rapid review confirmed that vitamin D fortification reliably raises blood 25(OH)D concentrations.

However, natural dietary sources are limited, which is one reason seasonal supplementation is recommended in the UK.

For people aged four years and older, SACN established a reference nutrient intake of:

10 micrograms per day

which equals:

400 IU per day.

NHS guidance advises adults and children over four to consider this amount during autumn and winter.

People at increased risk of deficiency—including those with little sunlight exposure and many people with dark skin—are advised to consider supplementation throughout the year.

These are population prevention recommendations, not treatment doses for confirmed deficiency.

Vitamin D labels frequently cause confusion because manufacturers use two different units.

The conversion is:

1 microgram = 40 IU

Therefore:

Always check the units before comparing products or medical advice.

Yes.

Vitamin D is fat soluble, and excessive supplementation can cause toxicity.

The major consequence is excessive calcium in the blood—hypercalcaemia.

Symptoms can include:

nausea, vomiting, reduced appetite, weakness, confusion, dehydration, excessive thirst, frequent urination, and kidney stones.

Severe toxicity can cause kidney failure, abnormal heart rhythms and calcium deposition in soft tissues.

The US Food and Nutrition Board's tolerable upper intake level for adults is:

100 micrograms/day = 4,000 IU/day

for routine unsupervised intake.

This upper limit is not a treatment protocol. Clinicians may intentionally prescribe different regimens for documented deficiency under medical supervision.

Ordinary sun exposure does not cause vitamin D toxicity.

The skin contains regulatory mechanisms that limit excessive vitamin D3 production, with excess precursor molecules converted into inactive products.

This does not make excessive UV exposure safe.

Ultraviolet radiation remains an established cause of skin damage and skin cancer. Vitamin D should therefore never be used as a justification for intentional sunburn or unsafe UV exposure.

High 25(OH)D usually raises a different question from low vitamin D:

How much vitamin D is the person taking?

Toxicity is overwhelmingly associated with excessive supplementation rather than ordinary food or sunlight exposure.

The NIH notes potential adverse effects at concentrations above approximately 125 nmol/L (50 ng/mL), while frank toxicity often involves much higher concentrations—commonly above approximately 375 nmol/L (150 ng/mL)—together with hypercalcaemia.

But a vitamin D number alone does not define toxicity.

Clinicians may also assess:

serum calcium, kidney function, symptoms, supplement dose, duration of supplementation, and sometimes urinary calcium or other investigations.

Both vitamin D2 and D3 can raise 25(OH)D.

Vitamin D3 often produces a greater or more sustained increase in circulating 25(OH)D in comparative studies, but both forms have clinical uses.

For most consumers following ordinary public-health supplementation advice, the more important issues are:

taking an appropriate amount, using a reliable product, avoiding unnecessary megadoses, and understanding why supplementation is being used.

Vitamin D and vitamin K participate in different aspects of bone and calcium biology, leading to widespread marketing of combined "D3 + K2" products.

The marketing claim is often much stronger than the clinical evidence.

There is no general guideline requirement that healthy adults taking standard preventive vitamin D doses must also take vitamin K2.

People taking anticoagulants that interfere with vitamin K pathways also need particular caution with vitamin K-containing supplements.

Do not assume a supplement combination is medically superior simply because the biological explanation sounds plausible.

A result deserves clinical interpretation rather than self-treatment when it occurs alongside circumstances such as:

very low 25(OH)D, significant bone pain or muscle weakness, recurrent or unexplained fractures, abnormal calcium or phosphate, suspected osteomalacia, significant kidney disease, significant liver disease, malabsorption, gastrointestinal surgery, unexpectedly high vitamin D, symptoms suggesting hypercalcaemia, or substantial high-dose supplement use.

Children with suspected rickets require professional assessment.

Likewise, severe symptoms should not be managed by simply buying increasingly high-dose supplements.

Blood Tests & Biomarkers

HbA1c Explained: Understanding Your Blood Sugar Over Time Ferritin Explained: Understanding Your Iron Stores Vitamin B12 Explained High Creatinine: What an Elevated Creatinine Blood Test Means Calcium Blood Test Explained Liver Enzymes Explained Thyroid Function Tests Explained Complete Blood Count Explained ALP Explained: Understanding Alkaline Phosphatase Parathyroid Hormone (PTH) Explained

Understanding Medical Reports

What Does "Unremarkable" Mean on a Scan? What Does "Mild Degenerative Changes" Mean? What Does "Clinical Correlation Recommended" Mean?

A vitamin D result is a snapshot. Your health is a timeline.

A single vitamin D measurement may be useful, but it becomes more meaningful when considered alongside previous results, calcium, phosphate, kidney function, medications, supplements, symptoms and relevant medical history.

Healio360 helps connect those pieces.

Bring medical reports and health information together, understand clinical terminology in plain language and follow important biomarkers over time.

Instead of asking only:

"Is my vitamin D normal?"

you can begin asking:

"Has it changed?"

"Was it measured in the same season?"

"What happened to my calcium and other results?"

"Did the change follow supplementation?"

"Is this isolated or part of a wider pattern?"

"What should I discuss with my healthcare professional?"

Turn fragmented health information into a clearer, longitudinal health story.

Healio360 provides educational health information and organisational tools. It does not diagnose disease, replace professional medical assessment or provide personalised treatment recommendations.